| Market Cap | ₹2,204.15 CrChemicals Sector |
|---|---|
| P/E Ratio | 32.1Sector PE: 33.64 |
| 1-Year Return | 185.36%Price Performance |
| RSI | 56.73Neutral Zone |
| Metric | Q2-27 | Q1-27 | Q2-26 |
|---|---|---|---|
| Revenue from Operations | 863 | 709 | 480 |
| Other Income | 20.6 | 6.1 | 19.9 |
| Total Income | 884 | 715 | 500 |
| Profit Before Tax | 90.0 | 39.1 | 5.6 |
| Exceptional Items | 0.0 | 0.0 | -0.0 |
| Net Profit | 81.4 | 30.4 | 6.0 |
| Operating Margin | 10.2% | 5.5% | 1.1% |
| Net Profit QoQ | +167.8% | ||
| Net Profit YoY | +1,256.7% | ||
| Adj. Profit QoQ | +110.3% | ||
| Adj. Profit YoY | +585.3% | ||
Key highlights
- Revenue from operations reached ₹863 crore in Q2 FY27, up from ₹480 crore in the same period last year
- Consolidated net profit climbed to ₹81.4 crore, marking a 1,256.7% year-on-year increase
- Operating margins expanded significantly to 10.2% compared to 1.1% in the year-ago quarter
- Other income for the quarter stood at ₹20.6 crore, rising from ₹6.1 crore in the preceding quarter
- The company reported a standalone net profit of ₹804.75 million for the quarter, reflecting strong domestic operations
Operational Scale and Revenue Momentum
Bodal Chemicals demonstrated significant operational scale during the second quarter of FY27, with revenue from operations reaching ₹863 crore. This represents a 79.8% increase compared to ₹480 crore in the corresponding quarter of the previous year. Sequentially, revenue grew 21.7% from ₹709 crore in Q1 FY27.
This performance brings the total revenue for the first half of FY27 to ₹1,572 crore, positioning the company well against its historical annual turnover guidance of approximately ₹2,000 crore. The growth was primarily driven by the company's chemical business segment, which remains its sole reportable operating segment according to the latest filing.
Margin Expansion and Expense Analysis
- Operating margins witnessed a sharp recovery, reaching 10.2% from a low of 1.1% in Q2 FY26
- Total expenses for the quarter stood at ₹793.97 crore, compared to ₹494.80 crore in the same period last year
- Cost of materials consumed was the primary expenditure at ₹522.16 crore, up from ₹242.78 crore YoY
- The company recognized a net profit of ₹81.4 crore, a 167.8% increase over the ₹30.4 crore reported in the preceding quarter
- Total income including other sources amounted to ₹884 crore, up from ₹500 crore in Q2 FY26
Subsidiaries and International Adjustments
The company's consolidated results reflect the performance of its subsidiaries across Turkey, Indonesia, and China. Notably, the firm applied Ind AS 29 regarding hyperinflationary economies for its Turkish operations, resulting in a net impact of ₹12.72 crore debited to the half-year profit and loss statement. Furthermore, Bodal Chemicals recognized an SGST incentive income of ₹47.88 crore for H1 FY27 under the Punjab Industrial Incentive Scheme.
These results come as the company continues to focus on its benzene downstream project at Saykha, which holds an estimated annual revenue potential of approximately ₹300 crore at optimal capacity utilization.
| Date | Announcement | Amount |
|---|---|---|
| 05 Aug 2026 | Q1 FY27 consolidated revenue from operationsSource: perivis.com | ₹709.04 Cr |
| 21 May 2026 | Q4 FY26 consolidated revenue from operationsSource: perivis.com | ₹588.02 Cr |
| 14 Feb 2026 | Q3 FY26 consolidated sales revenueSource: geojit.com | ₹489.57 Cr |
| 12 Nov 2025 | Q2 FY26 consolidated sales revenueSource: geojit.com | ₹480.45 Cr |
| 12 Aug 2025 | Q1 FY26 consolidated sales revenueSource: perivis.com | ₹454.20 Cr |
| 27 May 2025 | Q4 FY25 consolidated revenue from operationsSource: lemonn.co.in | ₹447.51 Cr |
What to watch next
- Reopening of the trading window for company securities on November 06, 2026
- Final verification of SGST incentive claims by the competent industrial authorities in Punjab
- Capacity utilization milestones at the Saykha benzene downstream project
- Performance of the Turkish subsidiaries under ongoing hyperinflationary accounting adjustments
| Share price | ₹175.01 |
|---|---|
| Market capitalisation | ₹2,204.15 Cr |
| Revenue (annual) | ₹2,012.24 Cr |
| Net profit (annual) | ₹47.83 Cr |
| Revenue (latest quarter) | ₹709.04 Cr+20.58% vs previous quarter |
| Net profit (latest quarter) | ₹30.38 Cr-5.24% vs previous quarter |
| P/E (TTM) | 32.1×Sector 33.64× |
| Promoter holding | 57%0.00% QoQ |
| FII holding | 1.79%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Bodal Chemicals Limited announcing its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Market figures from a third-party data provider.
